We identified a homozygous variation in SPRY3 in one T-ALL patient sample, and 3 mutations in SPRY4 (2 mutations in cell lines and 1 somatically acquired mutation in a T-ALL patient sample). Here, SPRY4 is linked to acute lymphoblastic leukemia.